Araz, M. Et Al. 2021. Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters. Cancer Biotherapy and Radiopharmaceuticals , vol.36, no.5 , 425-432.

Araz, M., Soydal, Ç., Özkan, E., Akkus, P., Nak, D., Küçük, N. Ö., ... Kır, K. M.(2021). Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters. Cancer Biotherapy and Radiopharmaceuticals , vol.36, no.5, 425-432.

Araz, MİNE Et Al. "Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters," Cancer Biotherapy and Radiopharmaceuticals , vol.36, no.5, 425-432, 2021

Araz, MİNE Et Al. "Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters." Cancer Biotherapy and Radiopharmaceuticals , vol.36, no.5, pp.425-432, 2021

Araz, M. Et Al. (2021) . "Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters." Cancer Biotherapy and Radiopharmaceuticals , vol.36, no.5, pp.425-432.

@article{article, author={MİNE ARAZ Et Al. }, title={Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters}, journal={Cancer Biotherapy and Radiopharmaceuticals}, year=2021, pages={425-432} }